Back
YieldMax AAPL Option Income Strategy ETF Vs. Amphastar Pharmaceuticals, Inc. Industry Stock Comparison
Sell
39
APLY
YieldMax AAPL Option Income Strategy ETF
Last Price:
$13.32
Seasonality Move:
-15.5%
Sell
40
AMPH
Amphastar Pharmaceuticals, Inc.
Last Price:
$26.53
Seasonality Move:
-3.24%
Sell
39
YieldMax AAPL Option Income Strategy ETF (APLY)
is a Sell
Is YieldMax AAPL Option Income Strategy ETF a Buy, Sell or Hold?
-
The current YieldMax AAPL Option Income Strategy ETF [APLY] share price is $13.41. The Score for APLY is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
-
APLY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
40
Amphastar Pharmaceuticals, Inc. (AMPH)
is a Sell
Is Amphastar Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Amphastar Pharmaceuticals, Inc. [AMPH] share price is $26.07. The Score for AMPH is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
-
AMPH is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
APLY Stock Price Chart
What is YieldMax AAPL Option Income Strategy ETF's stock price today?
-
The YieldMax AAPL Option Income Strategy ETF share price today is $13.41Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLY is experiencing selling pressure, which indicates risk of future bearish movement.
AMPH Stock Price Chart
What is Amphastar Pharmaceuticals, Inc.'s stock price today?
-
The Amphastar Pharmaceuticals, Inc. share price today is $26.07The current trend is relatively stagnant and AMPH is experiencing slight buying pressure.
APLY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.06 | Sell |
| Relative Strength Index (14 RSI): | 38.27 | Sell |
| Chaikin Money Flow: | -148852 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (13.58 - 13.94) | Sell |
| Bollinger Bands (100): | (13.19 - 13.89) | Sell |
AMPH Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.03 | Sell |
| Relative Strength Index (14 RSI): | 49.58 | Sell |
| Chaikin Money Flow: | 55695 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (25.62 - 27.22) | Sell |
| Bollinger Bands (100): | (23.9 - 28.88) | Sell |
APLY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 13.62 | Sell |
| 20-day SMA: | 13.76 | Sell |
| 50-day SMA: | 13.71 | Sell |
| 200-day SMA: | 13.56 | Sell |
| 8-day EMA: | 13.61 | Sell |
| 20-day EMA: | 13.71 | Sell |
| 50-day EMA: | 13.69 | Sell |
| 200-day EMA: | 14.09 | Sell |
AMPH Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 25.82 | Buy |
| 20-day SMA: | 26.42 | Sell |
| 50-day SMA: | 25.49 | Buy |
| 200-day SMA: | 25.64 | Buy |
| 8-day EMA: | 26.01 | Buy |
| 20-day EMA: | 26.15 | Sell |
| 50-day EMA: | 26.06 | Buy |
| 200-day EMA: | 27.92 | Sell |
YieldMax AAPL Option Income Strategy ETF Earnings Growth & APLY Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Amphastar Pharmaceuticals, Inc. Earnings Growth & AMPH Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.49 per share, and an increase next year of $0.20 per share.
YieldMax AAPL Option Income Strategy ETF Technical Analysis
| Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Amphastar Pharmaceuticals, Inc. Technical Analysis
| Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||